ASML entered the week having blown through €1,900 on a wave of analyst upgrades — and it ended Tuesday giving back a meaningful chunk of those gains in company with every major peer.
Tuesday's 5.7% drop to €1,560.80 is the headline number, but the peer context matters here. ASM International fell 7.9% on the day, Lam Research dropped 9.3%, Applied Materials lost 8.5%, and KLA declined 9.2%. ASML actually held up better than most of its closest peers on Tuesday — the selling was sector-wide, not stock-specific. Over the full week, ASML is down roughly 2%, while AMAT and KLAC are both still positive on the week, suggesting Wednesday-Friday action will determine whether Tuesday was a flush or the start of something more persistent.
The lending market offers no signal of serious short-side pressure. Availability is essentially unlimited — over 111 million shares remain available to borrow, with utilization running at just 0.22%, near the bottom of its 52-week range of 0.05–0.72%. Short interest is negligible, well under 0.1% of float, consistent with the prior note's reading of roughly 0.04%. Cost to borrow has eased to 0.64% after briefly spiking to 1.9% on June 19 — an episode that appears to have been driven by specific new-loan demand around the Euronext settlement cycle rather than any durable shift in short positioning. The borrow market, in short, remains as loose as it has been all year. There is no squeeze setup here.
The Street picture is complicated by stale formal consensus data, which the snapshot flags explicitly — the published consensus target of around $724 dates to May 2023 and should be disregarded entirely. What's current: as noted in the June 22 report, BofA's target of $2,345 and Wells Fargo and JP Morgan both at $2,200 represent the live anchor points, with ASML having traded roughly in line with or above those levels before Tuesday's drop. At €1,560.80, and with Q2 earnings due July 15, the stock is now sitting materially below where the most recent bullish calls were made — but that reflects currency conversion and the week's move, not a collapse in the fundamental thesis. Valuation multiples give a consistent read: the trailing P/E near 45.5x and EV/EBITDA near 35.6x have both drifted modestly lower over the past seven days but remain elevated, tracking the price move rather than any earnings revision. The ORTEX short score is essentially flat at 25.3, a very low reading that ranks in the 96th percentile for "low short pressure" — reinforcing the view that Tuesday's move was macro or sector-driven, not a sign of accumulating bearish conviction on the name.
Institutional ownership is broadly stable and supportive. BlackRock added 336,000 shares through May, bringing its holding to 7.2% of shares. Fidelity (FMR) added 827,000 shares through May 29, the largest reported recent addition in the top-15 holder list. JP Morgan Asset Management added 229,000 shares through June 1. The flow picture across major holders is uniformly in the direction of modest accumulation, with no notable trimming reported in recent filings.
With Q2 results due July 15, the question heading into the final weeks of June is whether Tuesday's sector-wide reset holds or gets compounded — and whether the export-control investigation flagged last week produces any new developments that shift the stock-specific narrative ahead of the print. The last two earnings reactions were both negative on the day (Q1 fell 4.8%, the April 22 update slipped 1.1%), making the July 15 setup worth watching closely as the stock re-approaches the price levels where the Street's most bullish calls were written.
See the live data behind this article on ORTEX.
Open ASML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
